Predict your next investment

Angel Investor (Group)
angelsfund.be

See what CB Insights has to offer

Investments

6

Portfolio Exits

3

Funds

2

About BAMS Angel Fund

BAMS Angels Fund is an early-stage investment fund organisation focused on investment rounds between EUR 1 and 4 million.BAMS Angels Fund I (BAF I) was created in 2005 by bringing together 30 individual œangel investors and selected institutional investors under the management of an experienced investment team. It invested in 9 early-stage projects in and around Belgium.In 2009, Michel Helbig de Balzac, Maurice Olivier and Bart Luyten launched BAMS Angels Fund II (BAF II) with the aim of scaling up and leveraging the positive experience of BAF I. The target size of BAMS Angels Fund II is upwards of EUR 20 million.BAMS Angels Fund aims to cover the equity gap faced by most promising start-up companies on their path towards profitable growth. The Fund has the resources, knowledge, experience and agility to respond to the financial and management needs of those companies, and to work side-by-side with them towards the achievement of successful exits.

BAMS Angel Fund Headquarter Location

Axisparc Business Center Rue Fond Cattelain 2/1.2

Mont Saint Guibert, 1435,

Belgium

+32 (0)10 48 50 20

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

BAMS Angel Fund Investments

6 Investments

BAMS Angel Fund has made 6 investments. Their latest investment was in Bone Therapeutics as part of their Series D on January 1, 2013.

CBI Logo

BAMS Angel Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/28/2013

Series D

Bone Therapeutics

$8.2M

Yes

1

12/15/2011

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/31/2010

Angel - II

Subscribe to see more

Subscribe to see more

10

10/15/2010

Series B

Subscribe to see more

$99M

Subscribe to see more

0

12/31/2008

Angel

Subscribe to see more

Subscribe to see more

10

Date

1/28/2013

12/15/2011

12/31/2010

10/15/2010

12/31/2008

Round

Series D

Series A

Angel - II

Series B

Angel

Company

Bone Therapeutics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$8.2M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

0

10

BAMS Angel Fund Portfolio Exits

3 Portfolio Exits

BAMS Angel Fund has 3 portfolio exits. Their latest portfolio exit was Nomadesk on February 17, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/17/2017

Acquired

$99M

1

2/5/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

10/2/2006

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

2/17/2017

2/5/2015

10/2/2006

Exit

Acquired

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

0

BAMS Angel Fund Fund History

2 Fund Histories

BAMS Angel Fund has 2 funds, including BAMS Angels Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

BAMS Angels Fund II

Early-Stage Venture Capital

Withdrawn

1

BAMS Angels Fund I

Subscribe to see more

Subscribe to see more

10

Closing Date

Fund

BAMS Angels Fund II

BAMS Angels Fund I

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Withdrawn

Subscribe to see more

Amount

Sources

1

10

BAMS Angel Fund Team

2 Team Members

BAMS Angel Fund has 2 team members, including current Managing Partner, Michel Helbig de Balzac.

Name

Work History

Title

Status

Michel Helbig de Balzac

Entrepreneur Invest

Managing Partner

Current

Bart Luyten

Managing Partner

Current

Name

Michel Helbig de Balzac

Bart Luyten

Work History

Entrepreneur Invest

Title

Managing Partner

Managing Partner

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.